Inpart Logo
LoginRegister
ICO
Closed:

Therapeutics for Glomerular and Autoimmune-related Kidney Diseases

Header

Chinook Therapeutics is a clinical-stage biotechnology company developing precision medicines for kidney diseases. They are seeking to develop therapeutics targeting molecular drivers of kidney disease progression. The company is interested in leveraging its precision medicine approach by identifying targets, mechanisms, and pathways with supporting biological validation data or genetic data showing strong correlation with human kidney disease.

Approaches of Interest

  • Primary glomerular diseases (e.g. IgAN, Alport syndrome, FSGS)
  • Autoimmune-related renal...

Opportunity types being sought:

  • Technology

  • Academic Researcher

  • Research Project

  • Spinout Company

  • Centre of Excellence

To see the full details and submit your response please register now.

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile
Powered ByInpart
An online matchmaking platform for university-industry collaboration. Learn More

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.